5086 studies found for:    Open Studies | "Immune System Diseases"
Show Display Options
Rank Status Study
21 Recruiting Participation in a Research Registry for Immune Disorders
Conditions: ADA-SCID;   Adenosine Deaminase Deficiency;   Wiskott- Aldrich Syndrome;   Primary Immunodeficiencies;   Severe Combined Immune Deficiency
Intervention:
22 Recruiting Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments
Conditions: Rheumatoid Arthritis;   Osteoarthritis;   Systemic Lupus Erythematosus;   Sjogren's Syndrome;   Scleroderma;   Spondylitis;   Gout;   Spinal Disease;   Chondrocalcinosis
Intervention:
23 Recruiting Assessment of Immunoglobulins (IgG) in a Long-term Non-interventional Study
Conditions: Primary Immunodeficiency (PID);   Secondary Immunodeficiency (SID);   Neurological Autoimmune Disease
Intervention: Other: Immunoglobulin G (IgG)
24 Recruiting Oral Bacteria and Immune System Problems Involved in Gum Disease (Periodontitis)
Conditions: Immunosuppression;   Periodontal Disease;   Healthy Subjects;   Healthy Volunteer
Intervention:
25 Recruiting ALL SCTped FORUM - Pharmacogenomic Study (add-on Study)
Condition: Acute Lymphoblastic Leukemia
Interventions: Genetic: Pharmacogenomics;   Other: Busulfan plasma level measurements
26 Recruiting Severe Asthma Research Program - University of Virginia
Condition: Asthma
Intervention:
27 Not yet recruiting A Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host Disease
Condition: Graft vs Host Disease
Intervention: Drug: KD025
28 Recruiting GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory Leukemia
Conditions: Leukemia, Acute Lymphoblastic;   Acute Myeloid Leukemia;   Mixed-Lineage Acute Leukemias
Interventions: Procedure: Allogeneic stem cell transplantation;   Drug: Fludarabine monophosphate;   Drug: Busulfan;   Drug: Bendamustine
29 Recruiting Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy
Condition: Primary IgA Nephropathy
Interventions: Drug: Hydroxychloroquine Sulfate;   Drug: Valsartan
30 Recruiting A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia
Conditions: Lymphoma;   Leukemia, Lymphocytic, Chronic, B-Cell
Interventions: Drug: Durvalumab;   Drug: Lenalidomide;   Drug: Rituximab;   Drug: Ibrutinib;   Drug: Bendamustine
31 Recruiting Childhood Asthma Perception Study
Conditions: Asthma;   Childhood Asthma
Interventions: Behavioral: PEF Feedback;   Behavioral: Control Feedback
32 Recruiting Efficacy and Tolerability of Entospletinib in Combination With Systemic Corticosteroids as First-Line Therapy in Adults With Chronic Graft Versus Host Disease (cGVHD)
Condition: Chronic Graft Versus Host Disease
Interventions: Drug: Entospletinib;   Drug: Placebo;   Drug: Systemic Corticosteroids
33 Not yet recruiting Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older
Condition: Atopic Dermatitis
Interventions: Drug: MSRD-100;   Drug: Vehicle
34 Not yet recruiting Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older
Condition: Atopic Dermatitis
Interventions: Drug: MSRD-100;   Drug: Vehicle
35 Not yet recruiting Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (LYMRIT-37-05)
Condition: Relapsed, Diffuse Large B-cell Lymphoma
Intervention: Drug: Betalutin
36 Not yet recruiting Dosimetry Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (LYMRIT-37-02)
Condition: Non-Hodgkin Lymphoma
Interventions: Drug: Betalutin with HH1 pre-dosing;   Drug: Betalutin with Rituximab pre-dosing
37 Recruiting Treatment Study of Denintuzumab Mafodotin (SGN-CD19A) Plus RICE Versus RICE Alone for Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma, B-cell;   Lymphoma, Large B-Cell, Diffuse;   Lymphoma, Follicular, Grade 3b;   Follicular Lymphoma, Grade 3b
Interventions: Drug: denintuzumab mafodotin;   Drug: rituximab;   Drug: ifosfamide;   Drug: carboplatin;   Drug: etoposide
38 Recruiting Phase III Efficacy, Safety, and Tolerability Study of HYQVIA/HyQvia and GAMMAGARD LIQUID/KIOVIG in CIDP
Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Interventions: Biological: HYQVIA;   Biological: 0.25% albumin placebo solution with rHuPH20;   Biological: IGIV
39 Recruiting MabionCD20® Compared to MabThera® in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Drug: Rituximab
40 Recruiting Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Condition: Graft vs Host Disease
Interventions: Biological: Begelomab;   Biological: Conventional Second-line Treatment

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years